The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation is out! ACCP was pleased to collaborate again as an endorsing member. Congrats to ACCP members @kazuhikokido, @AArmbruster09, and Jim Tisdale, who served on the writing panel.
That’s a wrap on #ACCPAM23! Thank you to all of our attendees, speakers, and staff for a successful meeting. We look forward to seeing everyone again next year in Phoenix!
@Peds_RX @CrismonUTCOP I've been so fortunate to have had the opportunity to share this year with you and the rest of the inaugural APLD class. Your class never ceased to amaze me with your commitment to this new program and your passion for our profession. I love your new title for Lyn, too!
Does a a novel symptom-based alcohol withdrawal syndrome protocol in a US Veterans cohort leads to significant clinical improvements in patient outcomes and safety? https://t.co/8sT4XYU5CR @accpamedprn
The authors sought to externally validate a previously published population pharmacokinetic (PK) model that was constructed with data from a single site. https://t.co/dSg5rwEeMs @accpimtrprn
So many new antiseizure drugs, how to choose the optimal agent for your pt?
Personalized medicine is key! 🔑
Excellent @PharmacoJournal 📑 on ASMs in critically ill adults" discussing
💊PK/PD
📈Drug monitoring
✅Drug selection
🧬Pharmacogenomics
& more! https://t.co/tmhwQHRqdL
Calling all ACCP members: The College is asking members to submit resources or tools used to develop effective teams at their practice site for the NCICLE Teaming Resources Challenge. Complete details are available here: https://t.co/0PJsn8YzEl
In the newest "From the Desk of the ACCP President," President Elizabeth Farrington encourages members to take stock in various “spring cleaning” steps to help everyone move forward on their pathway to continuous professional development. Read here: https://t.co/8iQUTqzmpE
ACCP’s new advocacy platform is now available for members to view! It summarizes the College’s advocacy and legislative priorities, as well as the advocacy strategies and legislative approaches employed to advance these priorities. Read the release here: https://t.co/bU1Iw4aca1
Led by #CMM experts, the ACCP CMM Academy program provides participants with a core understanding of CMM foundations, business case development, implementation and measurement, and evaluation and reporting. Enroll by April 30! Learn more: https://t.co/5i0kvQp8DB
Recent literature gathered from the growing use of peripheral vasopressors and hypertonic sodium suggests low risk of harm for initiating these emergent therapies peripherally, which may prevent delays and improve patient outcomes. https://t.co/s4gluu5ft9 @tykiser
Strategies to engage stakeholders; evaluating PGX evidence; coordinating lab testing, results interpretation and their integration into the EHR; identifying reimbursement avenues; educating providers & patients; & maintaining a successful program. https://t.co/c6Uc4CIogC
Dr. Courtney Montepara shares her experience involving APPE students in research with a cardiology pharmacist-led intervention on high-intensity statin prescribing upon discharge after acute myocardial infarction. Full text manuscript available at: https://t.co/ASiM3VF8Qv.